Reference 2016-275

REF:            2016-275

Subject:        Uveitis with a biologic treatment




In your Trust please supply the number of patients currently treated for Uveitis with a biologic treatment, including those on a Patient Access Scheme.


Please state the number of Uveitis patients treated, and where possible by each biologic drug:

  • Adalimumab
  • Etanercept
  • Infliximab
  • Rituximab
  • Other biologics


How many Psoriasis patients have been treated in the last 6 months with Fumaric acid esters (Fumaderm), If your trust can’t supply patients, please supply the number of packs of tabs




We have no current use of biologics for uveitis.


Use of fumaderm in the last 6 months is:

Fumaderm 120mg (pack of 70) – 255.4 packs

Fumaderm 30mg (pack of 40) – 24.45 packs


Visitor restrictions

To protect you and our staff during the current outbreak of Covid-19 we’ve put in place significant restrictions on hospital visitors.

Full details of these can be found on our website.

We would like to thank you for your understanding and helping us stop the spread of Covid-19.

Read More

Stay Home. Protect the NHS. Save Lives.